ArticleFrontiers in endocrinology2021

FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale.

Pia Adam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.